Related Experiment Video

Updated: Dec 7, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.6K

Coronavirus disease 2019 (COVID-19) complicated by Spontaneous Pneumomediastinum and Pneumothorax

Megan Gillespie1, Nathan Dincher1,2, Pamela Fazio3

  • 1Department of Emergency Medicine, Jefferson Health - Northeast, Philadelphia, PA, USA.

Respiratory Medicine Case Reports
|September 29, 2020
PubMed

Insights

Severe acute respiratory illness coronavirus disease 2019 (COVID-19) emerged in late 2019. This case report highlights rare complications like pneumomediastinum and pneumothorax in progressive COVID-19.

Area of Science:

  • Medicine
  • Virology
  • Public Health

Background:

  • The emergence of coronavirus disease 2019 (COVID-19) in Wuhan, China, in December 2019 marked the beginning of a global health crisis.
  • The World Health Organization declared COVID-19 a global pandemic by March 2020, underscoring the urgent need for clinical understanding.

Observation:

  • Clinical information regarding COVID-19 and its complications is continuously evolving.
  • Providers must stay updated on typical symptoms and imaging findings associated with COVID-19.

Findings:

  • This case report focuses on less commonly reported complications of progressive COVID-19.
  • Specific attention is given to spontaneous pneumomediastinum and spontaneous pneumothorax as potential outcomes.

Implications:

  • Familiarity with both typical and rare complications is crucial for effective patient management.
  • Recognizing these less common findings aids in timely diagnosis and treatment of severe COVID-19 cases.

Keywords:
COVID-19Coronavirus diseaseSpontaneous pneumomediastinumSpontaneous pneumothorax

More Related Videos

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats07:29

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

11.1K
International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure05:50

International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure

Published on: March 12, 2020

14.4K

Related Concept Videos

Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
686
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
851
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
670
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.1K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
581
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
848